Safety and Effectiveness of TurbAlign™ for Middle Turbinate Medialization After Functional Endoscopic Sinus Surgery

NANot yet recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

August 5, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

June 30, 2026

Conditions
Sinus Endoscopic SurgeryTurbinate
Interventions
DEVICE

Implantation of Spirair device into the middle turbinates

The Spirair implant is designed to separate the middle turbinate from the lateral nasal wall during the healing phase associated with nasal/sinus surgery.

DEVICE

TurbAlign

The Spirair implant is designed to separate the middle turbinate from the lateral nasal wall during the healing phase associated with nasal/sinus surgery

Trial Locations (5)

60005

Northwest Community Hospital, Arlington Heights

60612

Rush University Medical Center, Chicago

70072

Tandem Clinical Research, Marrero

71130

LSU Health Science Center, Shreveport

77030

Houston Methodist ENT Specialists, Houston

All Listed Sponsors
lead

Spirair, Inc

INDUSTRY

NCT07027267 - Safety and Effectiveness of TurbAlign™ for Middle Turbinate Medialization After Functional Endoscopic Sinus Surgery | Biotech Hunter | Biotech Hunter